Phibro Animal Health Co. (NASDAQ:PAHC – Get Free Report) Director E Thomas Corcoran purchased 5,000 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was acquired at an average cost of $20.02 per share, with a total value of $100,100.00. Following the completion of the acquisition, the director now directly owns 25,000 shares of the company’s stock, valued at $500,500. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Phibro Animal Health Price Performance
PAHC stock opened at $19.46 on Friday. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. The company has a market capitalization of $788.13 million, a P/E ratio of 60.81, a PEG ratio of 1.66 and a beta of 0.52. The business has a 50 day simple moving average of $18.51 and a 200-day simple moving average of $16.28. Phibro Animal Health Co. has a twelve month low of $9.40 and a twelve month high of $22.31.
Phibro Animal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.47%. The ex-dividend date of this dividend is Wednesday, September 4th. Phibro Animal Health’s payout ratio is currently 150.00%.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the stock. Bank of America boosted their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Barclays boosted their price target on shares of Phibro Animal Health from $10.00 to $13.00 and gave the company an “underweight” rating in a research report on Friday, May 10th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, Phibro Animal Health has an average rating of “Hold” and a consensus target price of $13.25.
View Our Latest Analysis on PAHC
About Phibro Animal Health
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
- Five stocks we like better than Phibro Animal Health
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- The Most Important Warren Buffett Stock for Investors: His Own
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- What is a Bond Market Holiday? How to Invest and Trade
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.